Approval summary for bortezomib for injection in the treatment of multiple myeloma

Saved in:
Bibliographic Details
Published inClinical cancer research Vol. 10; no. 12; pp. 3954 - 3964
Main Authors BROSS, Peter F, KANE, Robert, LEIGHTON, John, CHENG YI LIANG, LOSTRITTO, Richard T, MCGUINN, William D, MORSE, David E, RAHMAN, Atiqur, ROSARIO, Lilliam A, VERBOIS, S. Leigh, WILLIAMS, Grant, WANG, Yong-Cheng, FARRELL, Ann T, PAZDUR, Richard, ABRAHAM, Sophia, BENSON, Kimberly, BROWER, Margaret E, BRADLEY, Sean, GOBBURU, Jogarao V, GOHEER, Anwar, LEE, Shwu-Luan
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 15.06.2004
Subjects
Adult
Aged
Aged, 80 and over
Antineoplastic agents
Antineoplastic Agents - therapeutic use
Biological and medical sciences
Boronic Acids - therapeutic use
Bortezomib
Clinical Trials as Topic
Drug Approval
Female
Humans
Male
Medical sciences
Middle Aged
Models, Chemical
Multiple Myeloma - drug therapy
Pharmacology. Drug treatments
Proteasome Endopeptidase Complex - metabolism
Pyrazines - therapeutic use
Time Factors
Tumors
United States
United States Food and Drug Administration
United States
Antineoplastic agent
Immunopathology
Bortezomib
Treatment
Immunoglobulinopathy
Lymphoproliferative syndrome
Malignant hemopathy
Injection
Myeloma
Online AccessGet full text

Cover

Author MORSE, David E
KANE, Robert
VERBOIS, S. Leigh
RAHMAN, Atiqur
PAZDUR, Richard
MCGUINN, William D
WANG, Yong-Cheng
BROWER, Margaret E
CHENG YI LIANG
WILLIAMS, Grant
BROSS, Peter F
FARRELL, Ann T
LEE, Shwu-Luan
BRADLEY, Sean
ROSARIO, Lilliam A
ABRAHAM, Sophia
GOHEER, Anwar
LEIGHTON, John
LOSTRITTO, Richard T
GOBBURU, Jogarao V
BENSON, Kimberly
Author_xml – sequence: 1
  givenname: Peter F
  surname: BROSS
  fullname: BROSS, Peter F
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 2
  givenname: Robert
  surname: KANE
  fullname: KANE, Robert
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 3
  givenname: John
  surname: LEIGHTON
  fullname: LEIGHTON, John
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 4
  surname: CHENG YI LIANG
  fullname: CHENG YI LIANG
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 5
  givenname: Richard T
  surname: LOSTRITTO
  fullname: LOSTRITTO, Richard T
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 6
  givenname: William D
  surname: MCGUINN
  fullname: MCGUINN, William D
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 7
  givenname: David E
  surname: MORSE
  fullname: MORSE, David E
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 8
  givenname: Atiqur
  surname: RAHMAN
  fullname: RAHMAN, Atiqur
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 9
  givenname: Lilliam A
  surname: ROSARIO
  fullname: ROSARIO, Lilliam A
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 10
  givenname: S. Leigh
  surname: VERBOIS
  fullname: VERBOIS, S. Leigh
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 11
  givenname: Grant
  surname: WILLIAMS
  fullname: WILLIAMS, Grant
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 12
  givenname: Yong-Cheng
  surname: WANG
  fullname: WANG, Yong-Cheng
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 13
  givenname: Ann T
  surname: FARRELL
  fullname: FARRELL, Ann T
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 14
  givenname: Richard
  surname: PAZDUR
  fullname: PAZDUR, Richard
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 15
  givenname: Sophia
  surname: ABRAHAM
  fullname: ABRAHAM, Sophia
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 16
  givenname: Kimberly
  surname: BENSON
  fullname: BENSON, Kimberly
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 17
  givenname: Margaret E
  surname: BROWER
  fullname: BROWER, Margaret E
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 18
  givenname: Sean
  surname: BRADLEY
  fullname: BRADLEY, Sean
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 19
  givenname: Jogarao V
  surname: GOBBURU
  fullname: GOBBURU, Jogarao V
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 20
  givenname: Anwar
  surname: GOHEER
  fullname: GOHEER, Anwar
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
– sequence: 21
  givenname: Shwu-Luan
  surname: LEE
  fullname: LEE, Shwu-Luan
  organization: Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15905584$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15217925$$D View this record in MEDLINE/PubMed
BookMark eNpNkEtLxDAQgIOsuA_9CUoveqtOmqaP41J8wYKw6Dmk2Ql2aZo1SYX119u6K3qaGfjm9c3JpLMdEnJJ4ZZSXtxRyIsYUpbcKuViYPFQ0xMyo5znMUsyPhnyX2ZK5t5vAWhKIT0jU8oTmpcJn5H1crdz9lO2ke-NkW4faeui2rqAX9Y09U_ZdFtUobHdkEXhHaPgUAaDXYisjkzfhmbXYmT22Fojz8mplq3Hi2NckLeH-9fqKV69PD5Xy1WsOECIOQfGNyyhZY51pusEco0MZZFrVuYbBKRlDSCRIuRScZbxFLEoi6LYUNQJW5Cbw9zhgY8efRCm8QrbVnZoey-yLOOcF2wA-QFUznrvUIuda8ZfBQUxyhSjKDGKElW1FsDEKHPouzou6GuDm7-uo70BuD4C0ivZaic71fh_XAnDASn7Bkm0f9g
CitedBy_id crossref_primary_10_1021_jm800548b
crossref_primary_10_4161_cbt_29452
crossref_primary_10_1158_1535_7163_MCT_07_2444
crossref_primary_10_1111_petr_12113
crossref_primary_10_2217_imt_2017_0015
crossref_primary_10_1038_s41573_022_00542_z
crossref_primary_10_1111_j_1365_2141_2012_09099_x
crossref_primary_10_1016_S0003_4509_05_82301_6
crossref_primary_10_1098_rstb_2005_1701
crossref_primary_10_1177_20406207211066173
crossref_primary_10_1074_jbc_M111_329078
crossref_primary_10_1016_j_actbio_2023_11_029
crossref_primary_10_1016_j_bmc_2018_01_017
crossref_primary_10_1021_jm4002296
crossref_primary_10_4155_fmc_13_17
crossref_primary_10_1002_cpdd_744
crossref_primary_10_1002_med_20111
crossref_primary_10_1016_j_tetlet_2019_03_020
crossref_primary_10_1093_neuonc_nor198
crossref_primary_10_1007_s00280_006_0367_6
crossref_primary_10_1038_s41598_023_28940_2
crossref_primary_10_1016_j_tetlet_2020_152082
crossref_primary_10_1111_fcp_12221
crossref_primary_10_1016_j_bbcan_2004_09_005
crossref_primary_10_1124_dmd_112_047662
crossref_primary_10_2217_17520363_1_3_437
crossref_primary_10_1007_s40262_019_00803_y
crossref_primary_10_1016_j_xphs_2018_11_024
crossref_primary_10_1021_ja058320b
crossref_primary_10_3389_fimmu_2021_607044
crossref_primary_10_1016_S1734_1140_13_71494_4
crossref_primary_10_1016_j_chembiol_2012_09_015
crossref_primary_10_1016_j_bmcl_2009_02_011
crossref_primary_10_1158_0008_5472_CAN_06_0680
crossref_primary_10_1371_journal_pntd_0003352
crossref_primary_10_1007_s11095_015_1732_0
crossref_primary_10_1038_s41573_021_00320_3
crossref_primary_10_1021_jm400542h
crossref_primary_10_1016_j_bmc_2010_01_017
crossref_primary_10_1093_jjco_hym037
crossref_primary_10_1517_14728222_9_2_283
crossref_primary_10_5059_yukigoseikyokaishi_74_426
crossref_primary_10_1158_1078_0432_CCR_09_2882
crossref_primary_10_2165_00024669_200605060_00006
crossref_primary_10_1016_j_leukres_2013_10_018
crossref_primary_10_1517_14712598_2014_953050
crossref_primary_10_1002_chem_202202059
crossref_primary_10_3346_jkms_2005_20_4_598
crossref_primary_10_3390_ijms222111595
crossref_primary_10_1016_j_jpba_2014_04_016
crossref_primary_10_3109_10428194_2012_708026
crossref_primary_10_1016_j_jtauto_2021_100102
crossref_primary_10_1007_s11033_009_9491_9
crossref_primary_10_1039_c001036g
crossref_primary_10_1007_s10928_015_9445_x
crossref_primary_10_1021_acs_jmedchem_1c00604
crossref_primary_10_1016_j_bmc_2016_04_025
crossref_primary_10_1158_1078_0432_CCR_10_1950
crossref_primary_10_3389_fonc_2022_829007
crossref_primary_10_1039_C8MD00140E
crossref_primary_10_1089_adt_2010_0317
crossref_primary_10_1080_17474086_2016_1216311
crossref_primary_10_4155_fmc_13_40
crossref_primary_10_1016_j_drup_2004_11_002
crossref_primary_10_3389_fphar_2021_686874
crossref_primary_10_1124_dmd_120_000307
crossref_primary_10_1189_jlb_0907632
crossref_primary_10_1002_hep_21555
crossref_primary_10_1177_01926233221083527
crossref_primary_10_4161_15384047_2014_987093
crossref_primary_10_1208_s12249_010_9554_1
crossref_primary_10_1152_ajpendo_00126_2005
crossref_primary_10_1038_sj_leu_2404734
crossref_primary_10_1080_17425255_2019_1621839
crossref_primary_10_3389_fonc_2021_797549
crossref_primary_10_3390_ijms23148048
crossref_primary_10_1161_ATVBAHA_112_249342
crossref_primary_10_3390_v9110352
crossref_primary_10_1007_s00280_007_0424_9
crossref_primary_10_1016_j_leukres_2007_05_023
crossref_primary_10_1002_ange_201000728
crossref_primary_10_1038_s41419_017_0194_1
crossref_primary_10_1038_nrc3380
crossref_primary_10_1021_acs_orglett_9b01640
crossref_primary_10_1016_j_actbio_2020_12_015
crossref_primary_10_1016_j_bbmt_2009_07_016
crossref_primary_10_1016_j_ddtec_2018_08_002
crossref_primary_10_1021_cb2002544
crossref_primary_10_1016_j_bbamcr_2012_06_013
crossref_primary_10_1002_ejoc_200900075
crossref_primary_10_1158_1078_0432_CCR_11_0853
crossref_primary_10_1038_sj_leu_2405016
crossref_primary_10_2217_nnm_2020_0220
crossref_primary_10_3390_ph16081181
crossref_primary_10_1053_j_seminhematol_2012_04_007
crossref_primary_10_1080_10428190902919218
crossref_primary_10_1158_1535_7163_MCT_11_0814
crossref_primary_10_1002_hon_2179
crossref_primary_10_1158_1078_0432_CCR_08_1265
crossref_primary_10_3390_cells11010009
crossref_primary_10_1074_jbc_M115_710053
crossref_primary_10_1002_anie_201000728
crossref_primary_10_1038_nmeth779
crossref_primary_10_1074_jbc_M112_403154
crossref_primary_10_1016_j_yrtph_2016_10_012
crossref_primary_10_1158_1078_0432_CCR_09_0822
crossref_primary_10_1002_smll_201804591
crossref_primary_10_1016_j_tetlet_2023_154627
crossref_primary_10_1074_jbc_M600509200
crossref_primary_10_1517_14656566_2011_622266
crossref_primary_10_1007_s12672_016_0273_2
crossref_primary_10_18632_oncotarget_6361
crossref_primary_10_1021_jm900559x
crossref_primary_10_3390_cells11091543
crossref_primary_10_1158_1078_0432_CCR_10_1745
crossref_primary_10_1002_chem_201204290
crossref_primary_10_1158_0008_5472_CAN_08_3150
crossref_primary_10_1089_jayao_2016_0084
crossref_primary_10_12659_MSM_898323
crossref_primary_10_1191_1078155205jp160oa
crossref_primary_10_1002_ijc_28924
crossref_primary_10_1111_j_1365_2141_2005_05867_x
crossref_primary_10_1038_nm_1978
crossref_primary_10_1038_s41598_022_23659_y
crossref_primary_10_1016_j_canlet_2015_06_023
crossref_primary_10_1124_dmd_117_075226
crossref_primary_10_1016_j_leukres_2005_05_003
crossref_primary_10_1007_s40264_021_01132_5
crossref_primary_10_1111_j_1349_7006_2010_01662_x
crossref_primary_10_1039_c3ob41338a
crossref_primary_10_1038_sj_onc_1210744
crossref_primary_10_1016_j_nano_2009_07_001
crossref_primary_10_1158_0008_5472_CAN_15_0794
crossref_primary_10_1007_s12079_023_00784_5
crossref_primary_10_1124_mol_119_118653
crossref_primary_10_1016_j_pharmthera_2017_09_001
crossref_primary_10_1208_s12248_020_00448_x
crossref_primary_10_1016_j_cellsig_2016_03_015
crossref_primary_10_5059_yukigoseikyokaishi_76_1206
crossref_primary_10_1053_j_seminoncol_2004_11_005
crossref_primary_10_3390_ijms18040781
crossref_primary_10_1158_0008_5472_CAN_09_1449
crossref_primary_10_1007_s11095_017_2310_4
crossref_primary_10_3390_biomedicines10040873
crossref_primary_10_1074_jbc_M511607200
crossref_primary_10_1517_14656566_2011_525219
crossref_primary_10_1186_1476_4598_7_40
crossref_primary_10_1016_j_leukres_2006_03_005
crossref_primary_10_1158_1078_0432_CCR_06_2491
crossref_primary_10_1021_acs_orglett_6b02338
crossref_primary_10_1021_jacs_5b09773
crossref_primary_10_1111_j_1365_2990_2010_01155_x
crossref_primary_10_1021_jacs_8b06656
crossref_primary_10_1038_nrd_2017_33
crossref_primary_10_2146_ajhp070272
crossref_primary_10_1021_jm500045x
crossref_primary_10_1007_s12013_011_9186_4
crossref_primary_10_1111_j_1600_0609_2004_00406_x
crossref_primary_10_1517_14728222_2011_553610
crossref_primary_10_1128_mBio_00732_19
crossref_primary_10_1158_1078_0432_CCR_11_3007
crossref_primary_10_3390_md8040835
crossref_primary_10_1016_j_mam_2022_101144
crossref_primary_10_18632_oncotarget_5857
crossref_primary_10_1017_S0317167100010544
crossref_primary_10_1371_journal_pone_0222522
crossref_primary_10_18632_oncotarget_2903
crossref_primary_10_1111_j_1365_2141_2007_06641_x
crossref_primary_10_18632_oncotarget_6601
crossref_primary_10_1016_j_ijrobp_2005_05_007
crossref_primary_10_1016_j_pep_2012_10_009
crossref_primary_10_1016_j_tet_2009_06_042
crossref_primary_10_1158_1078_0432_CCR_12_1213
crossref_primary_10_1159_000091692
crossref_primary_10_3109_10428194_2013_837163
crossref_primary_10_1007_s00109_009_0469_9
crossref_primary_10_15252_embr_201948978
crossref_primary_10_2217_14796678_4_1_65
crossref_primary_10_1177_1087057115617456
crossref_primary_10_1200_JCO_2005_02_4950
crossref_primary_10_1021_np800578e
crossref_primary_10_1248_cpb_c16_00182
crossref_primary_10_3390_jcm12154916
crossref_primary_10_1097_01_mjt_0000245224_20913_0d
crossref_primary_10_1016_j_bmc_2014_04_032
crossref_primary_10_3390_biom4030862
crossref_primary_10_1038_s41929_019_0384_6
crossref_primary_10_1016_j_bmc_2008_10_075
crossref_primary_10_1158_1078_0432_CCR_06_0170
crossref_primary_10_1021_acsnano_0c05332
crossref_primary_10_1517_14728220902866851
crossref_primary_10_1158_1535_7163_MCT_06_0577
crossref_primary_10_1016_j_ijantimicag_2005_08_018
crossref_primary_10_1371_journal_pone_0084248
crossref_primary_10_1124_dmd_111_039164
crossref_primary_10_4161_cc_23882
crossref_primary_10_1038_s41467_017_01319_4
crossref_primary_10_1016_j_bbadis_2019_04_003
crossref_primary_10_18632_oncotarget_11489
crossref_primary_10_1016_j_drup_2008_08_002
crossref_primary_10_1038_bmt_2008_312
crossref_primary_10_1007_s00280_013_2267_x
crossref_primary_10_1074_jbc_RA119_008849
crossref_primary_10_1517_13543784_2014_920821
crossref_primary_10_3390_cancers16030670
crossref_primary_10_1021_acs_jmedchem_9b00736
crossref_primary_10_1016_j_bmcl_2015_06_015
crossref_primary_10_1016_j_lungcan_2010_06_005
crossref_primary_10_1016_j_neuro_2013_09_001
crossref_primary_10_1002_med_20155
crossref_primary_10_1021_ml200215j
crossref_primary_10_1002_adfm_201807941
crossref_primary_10_1016_j_beha_2007_09_008
crossref_primary_10_1016_j_polymer_2011_07_057
crossref_primary_10_1039_D2RE00099G
crossref_primary_10_1080_14737140_2017_1328280
crossref_primary_10_7314_APJCP_2015_16_4_1671
crossref_primary_10_1002_anie_201201616
crossref_primary_10_1016_j_regpep_2012_11_003
crossref_primary_10_1021_acsmedchemlett_4c00017
crossref_primary_10_1007_s10928_019_09670_3
crossref_primary_10_1158_1078_0432_CCR_13_0755
crossref_primary_10_18632_oncotarget_103
crossref_primary_10_1182_blood_2005_05_2091
crossref_primary_10_1016_j_febslet_2007_05_040
crossref_primary_10_3390_ph10020040
crossref_primary_10_1016_j_jinorgbio_2012_04_007
crossref_primary_10_1016_j_cnur_2016_10_004
crossref_primary_10_4155_fmc_11_187
crossref_primary_10_1016_j_bmcl_2016_10_024
crossref_primary_10_1158_1078_0432_CCR_12_2754
crossref_primary_10_1007_s00214_012_1203_1
crossref_primary_10_1002_jcp_21444
crossref_primary_10_1158_1535_7163_MCT_05_0147
crossref_primary_10_1038_ki_2011_502
crossref_primary_10_1039_C7AY00779E
crossref_primary_10_1111_bph_14436
crossref_primary_10_1016_j_jtct_2022_01_026
crossref_primary_10_1016_j_freeradbiomed_2006_03_003
crossref_primary_10_1016_j_hoc_2007_08_014
crossref_primary_10_1110_ps_083450408
crossref_primary_10_1245_s10434_011_1881_2
crossref_primary_10_1021_acs_jmedchem_9b00878
crossref_primary_10_1039_C7TB01297G
crossref_primary_10_1177_147323000803600301
crossref_primary_10_3390_ijms22168955
crossref_primary_10_1016_S0213_9251_08_71043_8
crossref_primary_10_1093_cid_ciad676
crossref_primary_10_1038_s41419_022_04790_0
crossref_primary_10_1177_0300985809358423
crossref_primary_10_1039_D1RA04127D
crossref_primary_10_1182_blood_2005_11_4541
crossref_primary_10_1158_0008_5472_CAN_05_0686
crossref_primary_10_1080_14756366_2023_2220084
crossref_primary_10_1111_j_1756_185X_2012_01737_x
crossref_primary_10_1530_ERC_14_0005
crossref_primary_10_1038_s41419_021_03535_9
crossref_primary_10_3390_ijms161226238
crossref_primary_10_1016_j_cjac_2022_100163
crossref_primary_10_1002_ange_201201616
crossref_primary_10_1016_j_semcancer_2015_02_006
crossref_primary_10_1152_physrev_00015_2006
crossref_primary_10_1186_s12885_015_1460_1
crossref_primary_10_1016_j_bmc_2016_06_021
crossref_primary_10_1080_14740338_2017_1259310
Cites_doi 10.1200/JCO.1999.17.7.2173
10.1016/S1357-2725(02)00390-4
10.1056/NEJM199911183412102
10.1038/sj.leu.2402866
10.1002/(SICI)1096-8652(199606)52:2<77::AID-AJH2>3.0.CO;2-2
10.1046/j.1365-2141.2003.04473.x
10.1093/clinchem/46.5.673
10.1056/NEJMoa032290
10.1002/1097-0142(197208)30:2<382::AID-CNCR2820300213>3.0.CO;2-C
10.1146/annurev.biochem.70.1.503
10.1016/S0889-8588(18)30341-1
10.1634/theoncologist.7-1-9
10.1200/JCO.2003.08.072
10.1021/bi981482i
10.1016/S0891-5849(01)00768-7
10.1200/JCO.1998.16.3.890
10.4065/78.1.34
10.1056/NEJM199607113350204
10.1081/DMR-120023683
10.1006/jmbi.1997.1334
10.1046/j.1365-2141.1998.00930.x
10.1126/science.274.5288.782
10.1056/NEJM199402173300709
10.1007/s11864-001-0040-6
10.1056/NEJMoa030288
10.1126/science.274.5288.787
10.1006/abbi.1999.1138
10.1200/JCO.2003.03.139
10.1128/MCB.16.7.3554
10.1182/blood.V85.11.3077.bloodjournal85113077
10.1093/annonc/mdg287
10.1128/MCB.16.11.6037
10.1200/JCO.1998.16.12.3832
10.1126/science.1073725
10.1046/j.1365-2141.2000.02012.x
10.1126/science.7725097
10.1200/JCO.1983.1.8.453
10.1006/jmbi.1994.1113
10.1021/bi00119a004
10.1182/blood-2002-03-0889
10.1016/S0092-8674(00)80929-0
10.1016/S0140-6736(89)91548-1
10.1182/blood.V84.3.950.950
10.1056/NEJMoa022340
ContentType Journal Article
Copyright 2004 INIST-CNRS
Copyright_xml – notice: 2004 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1158/1078-0432.ccr-03-0781
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1557-3265
EndPage 3964
ExternalDocumentID 10_1158_1078_0432_CCR_03_0781
15217925
15905584
Genre Clinical Trial, Phase II
Clinical Trial, Phase I
Clinical Trial
Randomized Controlled Trial
Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
.55
.GJ
08R
18M
1CY
29B
2FS
2WC
34G
39C
3O-
476
4H-
53G
5GY
5RE
5VS
6J9
AAPBV
AAUGY
ABOCM
ACGFO
ACIWK
ACPRK
ACSVP
ADBBV
ADCOW
ADNWM
AENEX
AETEA
AFFNX
AFHIN
AFOSN
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BR6
BTFSW
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
H13
H~9
IH2
IQODW
J5H
KQ8
L7B
LSO
MVM
OHT
OK1
P0W
P2P
QTD
RCR
RHF
RHI
RNS
SJN
TR2
UDS
VH1
W2D
W8F
WHG
WOQ
X7M
XFK
XJT
YKV
ZA5
ZCG
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c500t-55035d32197eb6fb207fe3ea87f397de0e19b00ae1e07ac53654ee89888d1ef23
ISSN 1078-0432
IngestDate Fri Oct 25 05:31:56 EDT 2024
Thu Sep 26 15:52:06 EDT 2024
Sat Sep 28 07:41:05 EDT 2024
Sun Oct 29 17:07:27 EDT 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Antineoplastic agent
Immunopathology
Bortezomib
Treatment
Immunoglobulinopathy
Lymphoproliferative syndrome
Malignant hemopathy
Injection
Myeloma
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c500t-55035d32197eb6fb207fe3ea87f397de0e19b00ae1e07ac53654ee89888d1ef23
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-News-3
content type line 23
OpenAccessLink https://aacrjournals.org/clincancerres/article-pdf/10/12/3954/1952616/zdf01204003954.pdf
PMID 15217925
PQID 66655583
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_66655583
crossref_primary_10_1158_1078_0432_CCR_03_0781
pubmed_primary_15217925
pascalfrancis_primary_15905584
PublicationCentury 2000
PublicationDate 2004-06-15
PublicationDateYYYYMMDD 2004-06-15
PublicationDate_xml – month: 06
  year: 2004
  text: 2004-06-15
  day: 15
PublicationDecade 2000
PublicationPlace Philadelphia, PA
PublicationPlace_xml – name: Philadelphia, PA
– name: United States
PublicationTitle Clinical cancer research
PublicationTitleAlternate Clin Cancer Res
PublicationYear 2004
Publisher American Association for Cancer Research
Publisher_xml – name: American Association for Cancer Research
References 2023011320452560100_B13
2023011320452560100_B14
2023011320452560100_B15
2023011320452560100_B16
2023011320452560100_B17
2023011320452560100_B18
2023011320452560100_B19
2023011320452560100_B50
2023011320452560100_B51
2023011320452560100_B10
2023011320452560100_B11
2023011320452560100_B12
2023011320452560100_B7
2023011320452560100_B6
2023011320452560100_B9
2023011320452560100_B8
2023011320452560100_B46
2023011320452560100_B47
2023011320452560100_B48
2023011320452560100_B49
2023011320452560100_B1
2023011320452560100_B40
2023011320452560100_B41
2023011320452560100_B3
2023011320452560100_B42
2023011320452560100_B2
2023011320452560100_B43
2023011320452560100_B5
2023011320452560100_B44
2023011320452560100_B4
2023011320452560100_B45
2023011320452560100_B35
2023011320452560100_B36
2023011320452560100_B37
2023011320452560100_B38
2023011320452560100_B39
2023011320452560100_B30
2023011320452560100_B31
2023011320452560100_B32
2023011320452560100_B33
2023011320452560100_B34
2023011320452560100_B24
2023011320452560100_B25
2023011320452560100_B26
2023011320452560100_B27
2023011320452560100_B28
2023011320452560100_B29
2023011320452560100_B20
2023011320452560100_B21
2023011320452560100_B22
2023011320452560100_B23
References_xml – ident: 2023011320452560100_B2
– ident: 2023011320452560100_B49
  doi: 10.1200/JCO.1999.17.7.2173
– ident: 2023011320452560100_B33
  doi: 10.1016/S1357-2725(02)00390-4
– ident: 2023011320452560100_B46
– ident: 2023011320452560100_B11
  doi: 10.1056/NEJM199911183412102
– ident: 2023011320452560100_B12
  doi: 10.1038/sj.leu.2402866
– ident: 2023011320452560100_B48
  doi: 10.1002/(SICI)1096-8652(199606)52:2<77::AID-AJH2>3.0.CO;2-2
– ident: 2023011320452560100_B47
  doi: 10.1046/j.1365-2141.2003.04473.x
– ident: 2023011320452560100_B10
– ident: 2023011320452560100_B42
  doi: 10.1093/clinchem/46.5.673
– ident: 2023011320452560100_B6
  doi: 10.1056/NEJMoa032290
– ident: 2023011320452560100_B16
  doi: 10.1002/1097-0142(197208)30:2<382::AID-CNCR2820300213>3.0.CO;2-C
– ident: 2023011320452560100_B26
  doi: 10.1146/annurev.biochem.70.1.503
– ident: 2023011320452560100_B1
  doi: 10.1016/S0889-8588(18)30341-1
– ident: 2023011320452560100_B40
  doi: 10.1634/theoncologist.7-1-9
– ident: 2023011320452560100_B51
  doi: 10.1200/JCO.2003.08.072
– ident: 2023011320452560100_B31
  doi: 10.1021/bi981482i
– ident: 2023011320452560100_B43
  doi: 10.1016/S0891-5849(01)00768-7
– ident: 2023011320452560100_B20
  doi: 10.1200/JCO.1998.16.3.890
– ident: 2023011320452560100_B13
  doi: 10.4065/78.1.34
– ident: 2023011320452560100_B21
  doi: 10.1056/NEJM199607113350204
– ident: 2023011320452560100_B45
  doi: 10.1081/DMR-120023683
– ident: 2023011320452560100_B30
  doi: 10.1006/jmbi.1997.1334
– ident: 2023011320452560100_B22
  doi: 10.1046/j.1365-2141.1998.00930.x
– ident: 2023011320452560100_B9
– ident: 2023011320452560100_B34
  doi: 10.1126/science.274.5288.782
– ident: 2023011320452560100_B3
  doi: 10.1056/NEJM199402173300709
– ident: 2023011320452560100_B50
  doi: 10.1007/s11864-001-0040-6
– ident: 2023011320452560100_B14
  doi: 10.1056/NEJMoa030288
– ident: 2023011320452560100_B35
  doi: 10.1126/science.274.5288.787
– ident: 2023011320452560100_B44
  doi: 10.1006/abbi.1999.1138
– ident: 2023011320452560100_B15
– ident: 2023011320452560100_B23
  doi: 10.1200/JCO.2003.03.139
– ident: 2023011320452560100_B37
  doi: 10.1128/MCB.16.7.3554
– ident: 2023011320452560100_B38
– ident: 2023011320452560100_B19
  doi: 10.1182/blood.V85.11.3077.bloodjournal85113077
– ident: 2023011320452560100_B41
– ident: 2023011320452560100_B24
  doi: 10.1093/annonc/mdg287
– ident: 2023011320452560100_B36
  doi: 10.1128/MCB.16.11.6037
– ident: 2023011320452560100_B4
  doi: 10.1200/JCO.1998.16.12.3832
– ident: 2023011320452560100_B39
  doi: 10.1126/science.1073725
– ident: 2023011320452560100_B25
  doi: 10.1046/j.1365-2141.2000.02012.x
– ident: 2023011320452560100_B29
  doi: 10.1126/science.7725097
– ident: 2023011320452560100_B17
  doi: 10.1200/JCO.1983.1.8.453
– ident: 2023011320452560100_B32
  doi: 10.1006/jmbi.1994.1113
– ident: 2023011320452560100_B27
  doi: 10.1021/bi00119a004
– ident: 2023011320452560100_B7
  doi: 10.1182/blood-2002-03-0889
– ident: 2023011320452560100_B28
  doi: 10.1016/S0092-8674(00)80929-0
– ident: 2023011320452560100_B18
  doi: 10.1016/S0140-6736(89)91548-1
– ident: 2023011320452560100_B5
  doi: 10.1182/blood.V84.3.950.950
– ident: 2023011320452560100_B8
  doi: 10.1056/NEJMoa022340
SSID ssj0014104
Score 2.3575025
SourceID proquest
crossref
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 3954
SubjectTerms Adult
Aged
Aged, 80 and over
Antineoplastic agents
Antineoplastic Agents - therapeutic use
Biological and medical sciences
Boronic Acids - therapeutic use
Bortezomib
Clinical Trials as Topic
Drug Approval
Female
Humans
Male
Medical sciences
Middle Aged
Models, Chemical
Multiple Myeloma - drug therapy
Pharmacology. Drug treatments
Proteasome Endopeptidase Complex - metabolism
Pyrazines - therapeutic use
Time Factors
Tumors
United States
United States Food and Drug Administration
Title Approval summary for bortezomib for injection in the treatment of multiple myeloma
URI https://www.ncbi.nlm.nih.gov/pubmed/15217925
https://search.proquest.com/docview/66655583
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEkhHhTHosP3KoUJ7Yb-1gqlgWpHJau1FuUhy2KIKl2WyT2X_CPmYkdN4UFsVyiJmomkefzeMb5ZoaQl-ACWM2EiaSwOhJc6KjIlYZ5JRTcIGGJwGzk-YfJ8al4v5TLweBHj7W03RTj8uLSvJL_0SpcA71iluwVNBuEwgX4DfqFI2gYjv-k4ykWBP-G9TxcClrLGcQG6eai-boq2tN39WdT9hmNi0AtR_ZLxyecfzdfGm-ju8IFXdJkicg4G_m6QGH_-HXXcb3l-I6OxsF4e_6sY20HhCAp2H3kmNb1aBH-Pi1CtvbHZv1ple_tRAhkTLlcTG88GVbrFX6_0niDKsGIJa4fRLC4rI-spGc_uXYlpf1azLUrcf67nZeq3XLwDxzPZictMSx1_V_262r_st4FFmIb_0iVoZgMxWQgJmM8QzHXyPUEbBeyBN8uA2sIWbHC0Vjdk31SGIh5denb7Lk7t9b5OajNupYpf45pWt9mcYfc9kEJnTqE3SUDU98jN-aednGfnHRAox5oFJBFd0BrTwPQ6KqmADQagEYbSzugUQ-0B-T06M1idhz5ZhxRKRnbRBDJcllxWOCwi44tEpZaw02uUgsubWWYibG8Zm5iw9K8lHwihTFKK6Wq2NiEPyQHdVObx4TG-aSoqpTnsVZCJlZzja5mVRWTyghrhmTcjVm2djVXsr_qakgO90Z2d5fUTIKLPSQvuqHOwHziNzGYCc32PIPoHSve8SF55DTQuxeidZ3IJ1d9m6fk5m52PCMHm7OteQ6e66Y4bLH0E3S2kUQ
link.rule.ids 315,783,787,27938,27939
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Approval+Summary+for+Bortezomib+for+Injection+in+the+Treatment+of+Multiple+Myeloma&rft.jtitle=Clinical+cancer+research&rft.au=Bross%2C+Peter+F.&rft.au=Kane%2C+Robert&rft.au=Farrell%2C+Ann+T.&rft.au=Abraham%2C+Sophia&rft.date=2004-06-15&rft.issn=1078-0432&rft.eissn=1557-3265&rft.volume=10&rft.issue=12&rft.spage=3954&rft.epage=3964&rft_id=info:doi/10.1158%2F1078-0432.CCR-03-0781&rft.externalDBID=n%2Fa&rft.externalDocID=10_1158_1078_0432_CCR_03_0781
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-0432&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-0432&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-0432&client=summon